◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › J › JUBLPHARMA

Jubilant Pharmova Limited (JUBLPHARMA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Jubilant Pharmova Limited (JUBLPHARMA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Noida, India with about 5,657 employees. Its market capitalization is roughly ₹169 billion. In the fiscal year ended 2026-03-31, JUBLPHARMA reported ₹82.3B in revenue and ₹4.0B in net income.

Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.

Interactive charts & full statements →

JUBLPHARMA Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-312022-03-31
Total Revenue₹82.3B₹71.9B₹66.4B₹62.2B—
Gross Profit₹52.3B₹45.8B₹42.2B₹40.0B—
Operating Income (EBIT)₹8.2B₹8.1B₹5.2B₹2.3B—
Net Income₹4.0B₹8.4B₹771M(₹610M)—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

JUBLPHARMA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-06-302025-03-31
Total Revenue₹22.2B₹22.7B₹21.2B₹18.8B₹19.2B
Gross Profit₹14.7B₹15.6B₹14.0B₹12.6B₹12.9B
Operating Income (EBIT)₹1.2B₹2.2B₹1.7B₹1.9B₹2.5B
Net Income₹565M₹1.2B₹559M₹1.0B₹1.5B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

JUBLPHARMA Free Cash Flow History

Cash flow2026-03-312025-03-312024-03-312023-03-312022-03-31
Dividends Paid(₹795M)(₹796M)(₹798M)(₹801M)—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

JUBLPHARMA Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-312022-03-31
Total Assets₹155.2B₹127.6B₹115.5B₹111.6B—
Total Liabilities₹84.3B₹65.2B₹61.3B₹57.6B—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive JUBLPHARMA viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← JUBLINGREAAll “J” companiesJUCY →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.